Table 2.
Microbiologic Tests for bacterial isolation, antibiotic therapy and biofilm production. The level of biofilm production was measured by the cBRT
| Patients | Blood culture before surgery | Hearth valve culture | Hearth valve sonication | Antibiotic therapy | Biofilm production | Vegetation (Cm) |
|---|---|---|---|---|---|---|
| N1 | Negative | Negative | S. aureus | Ceftriaxone; Piperacillin/Tazobactam | High | 1.4 |
| N2 | MRSA | MRSA | MRSA | Linezolid; Piperacillin/Tazobactam | Moderate | 1.2 |
| N3 | S. gallolyticus | Negative | S. gallolyticus | Ceftriaxone; Gentamicin | Moderate | 1.6 |
| N4 | S. aureus | Negative | S. aureus | Vancomycin; Meropenem | High | 1.5 |
| N5 | E. faecalis | Negative | E. faecalis | Piperacillin-Tazobactam; Ampicillin; Meropenem | High | 2.1 |
| N6 | S. gallolyticus | Negative | S. gallolyticus | Piperacillin-Tazobactam; Vancomycin | High | 2.2 |
| N7 | Negative | Negative | S. aureus | Ceftriaxone; Vancomycin; Piperacillin/Tazobactam | Moderate | 1.3 |
| N8 | E. faecalis | Negative | E. faecalis | Vancomycin | High | 1.8 |